Sumitomo Pharma Co Ltd
TSE:4506
Sumitomo Pharma Co Ltd
TSE:4506
Price:
339 JPY
0.89%
Updated:
May 21, 2024
Sumitomo Pharma Co Ltd
Interest Income Expense
|
Sumitomo Pharma Co Ltd
Interest Income Expense Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sumitomo Pharma Co Ltd
TSE:4506
|
Interest Income Expense
¥21.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
168%
|
CAGR 10-Years
22%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Interest Income Expense
-¥161.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Interest Income Expense
¥25.6B
|
CAGR 3-Years
136%
|
CAGR 5-Years
47%
|
CAGR 10-Years
96%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Interest Income Expense
¥30.7B
|
CAGR 3-Years
25%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Interest Income Expense
¥3.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Astellas Pharma Inc
TSE:4503
|
Interest Income Expense
-¥3.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
See Also
What is Sumitomo Pharma Co Ltd's Interest Income Expense?
Interest Income Expense
21.6B
JPY
21.6B
JPY
Based on the financial report for Dec 31, 2023, Sumitomo Pharma Co Ltd's Interest Income Expense amounts to 21.6B JPY.
What is Sumitomo Pharma Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
22%
22%
Over the last year, the Interest Income Expense growth was -39%.
You don't have any saved screeners yet
